Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma has informed BSE that its trading window for dealing in company securities will remain closed for all designated persons starting January 1, 2026. The closure will stay in place until 48 hours after the declaration of financial results for the quarter ending December 31, 2025. The date of the board meeting to consider these results will be communicated later. The intimation was signed by Managing Director Umang Alkesh Gosalia and is filed in line with SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine compliance announcement and does not impact shareholders directly. It restricts designated persons (such as directors and key employees) from trading in the stock before quarterly results are announced, which is standard practice for all listed companies.